Proteins interacting with monoamine transporters: current state and future challenges

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Plasma membrane and vesicular transporters for biogenic amines (dopamine, norepinephrine, serotonin) regulate neurotransmission.
• These monoamine transporters are key targets for psychiatric medications and are affected by psychostimulants like cocaine and amphetamines.

Purpose of the Study:

• To explore the complexity of monoamine transporter regulation through their interacting proteins.
• To understand how these interactions influence transporter function, homeostasis, and disease mechanisms.

Main Methods:

• Utilized yeast two-hybrid and proteomics approaches to identify transporter-interacting proteins.
• Analyzed emerging data on protein interactions to decipher transporter regulation rules.

Main Results:

• Identified a multitude of proteins interacting with monoamine transporters.
• Revealed that transporter function and regulation are more complex than previously thought.
• Began to elucidate mechanisms of monoamine homeostasis and psychostimulant action.

Conclusions:

• Monoamine transporters do not function in isolation but are part of complex regulatory networks.
• Understanding these protein interactions opens new avenues for pharmacological interventions.
• Further research is needed to fully characterize these interactions and their implications.